Pharma Breakout Handout_CSB38245_NSequeira_Singapore
2015 Annual Client Forum
Pharmaceuticals & Healthcare
Breakout: Re-thinking compliance
strategies in the age of disruption
Thursday, 5 March | Kerry Hotel Pudong, Shanghai
How can your business innovate within the constantly changing compliance
and regulatory landscape?
The life sciences industry faces unprecedented compliance challenges — and the
close regulatory scrutiny they undergo is unlikely to slow down anytime soon.
Join our leading global compliance and corporate lawyers for an interactive
session to discuss developing legal and commercial issues facing pharmaceuticals,
healthcare and medical devices companies in China and the rest of Asia Pacific.
Our panelists will also provide practical tips to implement a robust compliance
program, as well as explore the positive effects disruptive innovation could have for
your business and the pharmaceutical industry in general.
11:00 am - 12:30 pm
Partner, Hong Kong
Baker & McKenzie Compliance team
Partner, Hong Kong
Partner, Hong Kong
Head of Global Compliance Group
Mini vandePol has been listed in the Australian Financial Review’s “Best Lawyers” under Commercial Litigation in 2012, 2013 and 2014 and
cited as one of the “key individuals” in Dispute Resolution by Chambers Global. Before becoming the head of Baker & McKenzie’s Global
Compliance Group, she was the head of the Asia Pacific Dispute Resolution Group for five years. She has over 20 years of experience in
representing dispute and litigation matters including conducting internal and regulator driven investigations. Mini advises companies on
anti-bribery and corruption compliance issues, conflicts of interest and legal professional privilege. She is a trusted advisor to a variety
of corporate boards and senior management and has worked with them to manage dispute matters and develop practical and tailored
BAKER & MCKENZIE COMPLIANCE TEAM
Richard Dean focuses on the US Foreign Corrupt Practices Act (FCPA) and related legislation, including US money laundering laws and their
application to the activities of global companies in emerging markets such as the former Soviet Union, China, Indonesia and Latin America.
He has an in-depth understanding of the key political, economic and cultural issues facing organizations doing business in these challenging
Listed by Chambers Asia Pacific as a leading lawyer in life sciences in China, Michelle Gon advises on issues related to investment, regulatory and
compliance from the perspective of anti-bribery, the Foreign Corrupt Practices Act (FCPA), anti-unfair competition and anti-fraud. Before rejoining Baker & McKenzie in 2005, she was the chief legal officer of a large NYSE- and HKSE-listed high-tech company with headquarters in China
and previously an international counsel for a multinational, which provided her exposure to various practice areas and industries. The Asian Legal
Business has named her one of the top 30 attorneys in China and one of the top 100 attorneys in Asia Pacific.
Simon Hui is a partner in Baker & McKenzie’s Dispute Resolution Practice Group in Shanghai. He has 18 years of experience and focuses
his practice on commercial and insurance dispute resolution, and regulatory and compliance matters.
Andrew Martin heads the Corporate & Securities practice at Baker & McKenzie.Wong & Leow in Singapore and is recognized as a leading
lawyer by Chambers Asia Pacific and Legal 500. Having practiced in England, Hong Kong, Australia and Singapore, he is well equipped to advise
multinationals and private equity houses from Asia, the US and Europe on their investments and business conduct in Asia Pacific. His practice
focuses on cross-border M&A and joint ventures, including post-acquisition integration and restructuring. He has also advised extensively on
compliance and governance matters, especially anti-bribery issues in which he supports clients’ internal investigation and compliance programs.
Joan Meyer has handled investigations and resolutions with enforcement authorities involving anti-corruption, government contracting and
the false claims act and financial fraud for companies. As a part of Baker’s white collar defense practice, she has handled investigations
and resolutions with enforcement authorities involving anti-corruption, government contracting and the false claims act and financial fraud
Clement Ngai primarily handles general IP advice, as well as enforcement and anti-piracy programs in Asia. He has extensive IP enforcement
experience in many jurisdictions in Asia (Hong Kong, Taiwan, Korea, China, Singapore and India), running anti-piracy programs for the software
industry in those countries. He also advises on general IP-related matters, software copyright issues, computer and IT matters, patent strategy,
R&D IP issues, IP security, and government lobbying on IP laws. One of his main focuses in on China, where he spends most of his time.
RELATED COMPLIANCE MATERIALS
5 Essential Elements of Corporate Compliance
Global Compliance News www.globalcompliancenews.com
Our new guide helps companies meet the demands of
enforcement authorities around the world by organizing
compliance around five essential elements: leadership,
risk assessment, standards and controls, training and
communication and oversight. We’ve included specific
recommendations that companies can take to ensure they are
fulfilling the requirements of each element.
A news platform moderated by Baker & McKenzie; one source
for all Compliance-related topics.
Free up-to-date information in English language on new or
amended laws and regulations, important court decisions,
impactful decisions by public authorities and relevant market
developments from more than 50 countries.
© 2015 Baker & McKenzie. All rights reserved. Baker & McKenzie International is a Swiss Verein with member law firms around the world. In accordance with the common terminology used in professional service organizations,
reference to a “partner” means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an “office” means an office of any such law firm.
This may qualify as “Attorney Advertising” requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.